Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2031 (LINC02031) is a human long intergenic non-coding RNA (lincRNA) annotated in NCBI Gene (Gene ID: 102724617)[5][3]. It is a non-coding RNA molecule, meaning it does not encode a protein product, and belongs to the lincRNA family, a subgroup of long non-coding RNAs that are transcribed from regions of the genome lying between protein-coding genes[5][3]. There are no commonly used aliases beyond the systematic gene symbol. As of September 2025, there is no experimentally established biological function, disease association, or report of LINC02031 being a direct therapeutic target or biomarker in humans[5][3]. No drugs are known to interact with this RNA, and it is not reported in the context of clinical diagnostics or therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2031 (LINC02031).